Sanofi Challenges EMA’s Refusal Of New Active Substance Status For Nexviadyme

 
• By Neena Brizmohun

Sanofi wants the European Medicines Agency to re-examine its opinion that the company’s drug for Pompe disease does not qualify as a new active substance.

The EMA will conduct the re-examination after Sanofi has submitted its grounds for the request • Source: Alamy

More from Europe

More from Geography